Metformin and/or Clomiphene Do Not Adversely Affect Liver or Renal Function in Women with Polycystic Ovary Syndrome

CONTEXT: Nonalcoholic fatty liver disease is common to insulin-resistant states such as polycystic ovary syndrome (PCOS). Metformin (MET) is often used to treat PCOS but information is limited as to its effects on liver function. OBJECTIVE: We sought to determine the effects of MET on serum hepatic...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Aubuchon, Mira, Kunselman, Allen R., Schlaff, William D., Diamond, Michael P., Coutifaris, Christos, Carson, Sandra A., Steinkampf, Michael P., Carr, Bruce R., McGovern, Peter G., Cataldo, Nicholas A., Gosman, Gabriella G., Nestler, John E., Myers, Evan R., Legro, Richard S.
Format: Artigo
Sprache:Inglês
Veröffentlicht: Endocrine Society 2011
Schlagworte:
JCEM Online: Brief Reports
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3200244/
https://ncbi.nlm.nih.gov/pubmed/21832111
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jc.2011-1093
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge